GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Cash From Discontinued Investing Activities

Betta Pharmaceuticals Co (SZSE:300558) Cash From Discontinued Investing Activities : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Betta Pharmaceuticals Co's cash from discontinued investing activities for the three months ended in Mar. 2025 was ¥0 Mil. It means Betta Pharmaceuticals Co received ¥0 Mil from discontinued investing activities. Betta Pharmaceuticals Co's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.


Betta Pharmaceuticals Co Cash From Discontinued Investing Activities Historical Data

The historical data trend for Betta Pharmaceuticals Co's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Cash From Discontinued Investing Activities Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash From Discontinued Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Betta Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash From Discontinued Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Betta Pharmaceuticals Co Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Betta Pharmaceuticals Co Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines